Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 149 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
1481 7.6 months Advanced Castration-Resistant Prostate Cancer 2 Chemotherapy
University of Siena Italy 3/2015
Treatment Details: Patients: This phase 2 study involved 31 pretreated advanced castration-resistant prostate cancer patients with a median age of 73 years. Treatment: Patients received low-dose acetylsal
 
1482 7.6 months Metastatic Melanoma 5 Chemotherapy
Mary Crowley Cancer Research Center United States 7/2009
Treatment Details: Patients: There were 74 patients with metastatic melanoma involved in this Phase II trial. Of these, 50 (67.6%) were male. The median patient age was 58 years old, with a range of 27-79.
 
1483 7.6 months Advanced NSCLC 4 Biologic therapy
Sarah Cannon Research Institute United States 6/2011
Treatment Details: Patients: This study involved previously treated advanced non-small cell lung cancer patients who were divided into 2 treatment groups. Group A consisted of 111 patients with a median age
 
1484 7.6 months Recurrent GBM 4 Chemotherapy
Centre Hospitalier Universitaire Vaudois Switzerland 2/2011
Treatment Details: Patients: This study involved 37 glioblastoma patients who had previously been treated and had recurrence or progression of their disease. The median patient age was 57 years and 76% were
 
1485 7.6 months Malignant glioma 4 Chemotherapy
Radiation
Institut Clinic de Malalties Hemato-Oncologique, Hospital Clinic, University of Barcelona Spain 2/2002
Treatment Details: Patients: This Phase II study involved 17 patients with malignant glioma and large residual disease after surgery or biopsy. Fourteen patients had glioblastoma multiforme and 3 patients had
 
1486 7.6 months Recurrent GBM 5 Chemotherapy
Duke University Medical Center United States 4/2004
Treatment Details: Patients: This Phase II study involved 56 patients with glioblastoma multiforme, 18 with anaplastic astrocytoma, and 2 with anaplastic oligodendroglioma. Patients were either newly diagnose
 
1487 7.6 months Advanced or metastatic breast cancer 4 Chemotherapy
Churchill Hospital United Kingdom 5/2002
Treatment Details: Patients: This Phase II study involved 44 women with advanced and/or metastatic breast cancer. Most patients had been treated previously with other regimens. Patients were divided into two
 
1488 7.6 months Advanced NSCLC 4 Chemotherapy
US Oncology, Inc. United States 2/2003
Treatment Details: Patients: This Phase II study involved 51 patients with advanced (stage IIIB or IV) non-small cell lung cancer. The median age of the patients was 64. Treatment: The treatment consisted
 
1489 7.6 months MPM 3 Biologic therapy
Netherlands Cancer Institute Netherlands 5/2005
Treatment Details: Patients: This Phase II study involved 40 patients with malignant pleural mesothelioma. Thirty-four patients were men, and six were women. The median age was 62 years. All but one patient
 
1490 7.5 months metastatic NSCLC 3 Chemotherapy
Taipei Veterans Center Taiwan Region 4/2005
Treatment Details: Patients: This Phase II study involved 20 patients who failed to respond to cisplatin-based therapy. Nine patients were men, and eleven were women. The average age was 61.4 years. All pat
 
Page 149 of 187  | Previous Page  | Next Page